Nogi, Japan

Naoki Kobayashi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Kobayashi. Retrieved from https://idiyas.com/inventor/naoki-kobayashi-9uibbd9m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoki Kobayashi: Innovator in AMPK Activator Research

Introduction

Naoki Kobayashi is a prominent inventor based in Nogi-machi, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of methods for screening AMPK activators. His innovative work has the potential to impact various therapeutic areas.

Latest Patents

Kobayashi holds a patent for an AMPK activator screening method. This patent describes a method for screening an AMPK activator, wherein the inhibition of an interaction between prohibitin and AMPK is used as an index. Additionally, the patent includes an AMPK activator that comprises, as an active ingredient, a compound inhibiting the interaction between prohibitin and AMPK, along with a prohibitin-AMPK complex.

Career Highlights

Naoki Kobayashi is associated with Kyorin Pharmaceutical Co., Ltd., where he continues to advance his research. His work has garnered attention for its innovative approach to understanding AMPK activators and their potential applications in medicine.

Collaborations

Kobayashi has collaborated with notable colleagues, including Tomohiro Ide and Yunike Akasaka. These partnerships have contributed to the advancement of research in the field.

Conclusion

Naoki Kobayashi's contributions to AMPK activator research highlight his role as an influential inventor in the biochemistry sector. His innovative methods and collaborations continue to pave the way for future advancements in this important area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…